Product Recalls in District of Columbia

Product recalls affecting District of Columbia — including food, drugs, consumer products, medical devices, and vehicles distributed to District of Columbia. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,655 recalls have been distributed to District of Columbia in the last 12 months.

47,654 total recalls
2,655 in last 12 months

Showing 27612780 of 47,654 recalls

Medical DeviceMarch 14, 2025· Merit Medical Systems, Inc.

Recalled Item: Merit Medical Recalled by Merit Medical Systems, Inc. Due to Update to IFU...

The Issue: Update to IFU to provide additional information related to risk with device...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceMarch 14, 2025· Merit Medical Systems, Inc.

Recalled Item: Merit Medical Recalled by Merit Medical Systems, Inc. Due to Update to IFU...

The Issue: Update to IFU to provide additional information related to risk with device...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
FoodMarch 13, 2025· Seabear Company

Recalled Item: SeaBear Smokedhouse Salmon Chowder is packaged in flexible retort pouch...

The Issue: Recall was initiated due to potential failure of the seal and potential to...

Recommended Action: Do not consume. Return to store for a refund or discard.

Class II — Potential Health HazardOngoing
Refund
FoodMarch 13, 2025· Seabear Company

Recalled Item: SeaBear Smokedhouse Alehouse Clam Chowder is packaged in retort pouch...

The Issue: Recall was initiated due to potential failure of the seal and potential to...

Recommended Action: Do not consume. Return to store for a refund or discard.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Dr. Reddy's Laboratories, Inc.

Recalled Item: Levetiracetam 0.75% in Sodium Chloride Injection 1 Recalled by Dr. Reddy's...

The Issue: LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Cetirizine Hydrochloride Tablets Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Ranolazine Extended-Release Tablets 1000mg Recalled by Glenmark...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Fenofibrate Capsules 67 mg Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Frovatriptan Succinate Tablets 2.5mg Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Naproxen Sodium Tablets Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Metformin Hydrochloride Extended-Release Tablets 1000mg Recalled by Glenmark...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Solifenacin Succinate Tablets 5mg Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Gabapentin Tablets 600mg Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Prochlorperazine Maleate Tablets Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Saxagliptin Tablets Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Lacosamide Tablets 150mg Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Propafenone Hydrochloride Extended-Release Capsules 325mg Recalled by...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Voriconazole Tablets 50mg Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund